Latest news
Is Haemonetics Corp (HAE) Undervalued After Q1 Results? EPS $0.7 - GuruFocusGuruFocus · Thu, 06 Aug 2026 13:28:23 GMTHaemonetics (NYSE: HAE) grows revenue 5.6% in Q1 2027 - Stock TitanStock Titan · Thu, 06 Aug 2026 10:09:59 GMTCan New VASCADE MVP XL Data Strengthen Haemonetics' (HAE) Moat in Electrophysiology Adjacent Markets? - simplywall.stsimplywall.st · Tue, 04 Aug 2026 20:49:05 GMTHaemonetics (HAE) Is Up 5.1% After New VASCADE MVP XL Real-World Study Data Release – Has The Bull Case Changed? - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 20:10:01 GMT